Mediar Therapeutics has entered a global licensing agreement with Eli Lilly and Company to progress the human immunoglobulin ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

Averaging up to 20% of weight loss, adults taking Tirzepatide had at least 25 fewer breathing interruptions each hour as they ...

A new review highlights the future of anti-obesity medications that could outperform today's already blockbuster drugs like ...